IL-36 Signaling in the Tumor Microenvironment

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Tumor growth control relies on immune cell activation and recruitment into the tumor microenvironment (TME).
• Soluble cytokines orchestrate immune surveillance, mobilizing antitumor immune cells like B cells and T cells.
• The interleukin-36 (IL-36) cytokine family has dual roles, implicated in autoimmune diseases and therapeutic antitumor immunity.

Purpose of the Study:

• To explore the biological role of IL-36 family cytokines in cancer.
• To evaluate the potential of IL-36 cytokines in designing novel cancer interventional therapies.

Main Methods:

• Review of existing literature on IL-36 cytokines and their function in the TME.
• Analysis of the immunomodulatory properties of IL-36 family members in preclinical and clinical cancer research.

Main Results:

• IL-36 cytokines are critical mediators of inflammation that can promote antitumor immune responses.
• Dysregulation of IL-36 signaling may impact cancer progression and therapeutic outcomes.
• The IL-36 pathway presents a potential target for cancer immunotherapy.

Conclusions:

• IL-36 cytokines play a significant role in modulating the immune response within the tumor microenvironment.
• Targeting the IL-36 pathway offers a promising strategy for enhancing cancer immunotherapy and treatment efficacy.